Vanberra Signal
Free trial

Femto Diagnostics

Curated by Signal

Point-of-care diagnosis of Acute Myocardial Infarction (AMI) and Congestive Heart Failure (CHF).

High Technologyfemtodx.com

Overview

Femto Diagnostics, a medical device start-up is developing wearable sensing devices for cardiovascular diseases such as Acute Myocardial Infarction (AMI) and Congestive Heart Failure (CHF) with a panel of clinically validated cardiac biomarkers. Device will come with mobile connectivity required to communicate from the patient location (home or ambulance) to the doctor's office or emergency room.

Key facts

Founded
2015
Headquarters
Boston, United States
Stage
Sign up to view
Industry
High Technology

Business model

2 products and services
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More High Technology companies

  • Neuros

    Wearable solution to improve sleep quality

    High TechnologyBothell, United States

  • Faction AI

    Provider of AI and IoT-based sensor data management platforms

    High TechnologyPlano, United States

  • Mobifusion

    Provides content based messaging bots and applications

    High TechnologySunnyvale, United States

About Femto Diagnostics

What does Femto Diagnostics do?

Femto Diagnostics, a medical device start-up is developing wearable sensing devices for cardiovascular diseases such as Acute Myocardial Infarction (AMI) and Congestive Heart Failure (CHF) with a panel of clinically validated cardiac biomarkers.

Where is Femto Diagnostics headquartered?

Femto Diagnostics is headquartered in Boston, United States.

When was Femto Diagnostics founded?

Femto Diagnostics was founded in 2015.

Which sector is Femto Diagnostics in?

Femto Diagnostics operates in High Technology.

Who are Femto Diagnostics's competitors?

Companies similar to Femto Diagnostics include Neuros, Faction AI, and Mobifusion.